<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01172431</url>
  </required_header>
  <id_info>
    <org_study_id>WestChinaH</org_study_id>
    <nct_id>NCT01172431</nct_id>
  </id_info>
  <brief_title>Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency</brief_title>
  <official_title>A Comparison of Indapamide SR 1.5 mg With Hydrochlorothiazide 25 mg, in Combination With an ACE-inhibitor, in Old Patients With Mild to Moderate Renal Insufficiency and Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>West China Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effects of indapamide SR 1.5 mg on renal
      function, endothelial function, blood pressure variability by comparison with
      hydrochlorothiazide 25 mg, in patients with Mild to Moderate Renal Insufficiency and
      Hypertension.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>renal function</measure>
    <time_frame>1 year</time_frame>
    <description>Effects of indapamide SR 1.5 mg on renal function by comparison with hydrochlorothiazide 25 mg, in patients with Mild to Moderate Renal Insufficiency and Hypertension.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>endothelial function</measure>
    <time_frame>1 year</time_frame>
    <description>Effects of indapamide SR 1.5 mg on endothelial function by comparison with hydrochlorothiazide 25 mg, in patients with Mild to Moderate Renal Insufficiency and Hypertension.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure variability</measure>
    <time_frame>1 year</time_frame>
    <description>Effects of indapamide SR 1.5 mg on blood pressure variability by comparison with hydrochlorothiazide 25 mg, in patients with Mild to Moderate Renal Insufficiency and Hypertension</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">240</enrollment>
  <condition>Hypertension</condition>
  <condition>Renal Insufficiency</condition>
  <arm_group>
    <arm_group_label>Indapamide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Indapamide SR 1.5mg qd</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydrochlorothiazide</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hydrochlorothiazide 25mg qd</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Indapamide</intervention_name>
    <description>Indapamide SR 1.5mg qd</description>
    <arm_group_label>Indapamide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrochlorothiazide</intervention_name>
    <description>Hydrochlorothiazide 25mg qd</description>
    <arm_group_label>Hydrochlorothiazide</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Creatinine clearance 30 to 90 mL/min/1.73 m2, with variations of less than 20 percent
             in the 2 weeks before the screening evaluation.

          -  Diagnosed hypertension according to guidelines or having taken anti-hypertension
             drugs.

          -  Aged between 65 and 85 years.

          -  Willingness to provide written, informed consent.

          -  Ability to adhere to study protocol.

        Exclusion Criteria:

          -  Secondary hypertension.

          -  Diabetes mellitus.

          -  Atrial flutter/atrial fibrillation.

          -  Symptoms of congestive heart failure (NYHA III-IV) or there is evidence that left
             ventricular EF &lt; 40%.

          -  Recent (&lt; 6 months) myocardial infarction or cerebrovascular ischemic symptoms.

          -  Recent (&lt; 3 months) or planned coronary revascularization: PCI (percutaneous coronary
             intervention)/CABG (coronary artery by-pass graft).

          -  Severe valvular heart disease.

          -  History of hypersensitivity to indapamide, thiazides or to any of the components of
             the products.

          -  Any current condition or other disease known to interfere significantly with the
             absorption, distribution, metabolism or excretion of study drugs.

          -  Participation to another investigational study in the last 3 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiao P Chen, master</last_name>
    <role>Principal Investigator</role>
    <affiliation>West China Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Cardiology, West China Hospital, Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 26, 2010</study_first_submitted>
  <study_first_submitted_qc>July 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2010</study_first_posted>
  <last_update_submitted>June 23, 2014</last_update_submitted>
  <last_update_submitted_qc>June 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>West China Hospital</investigator_affiliation>
    <investigator_full_name>Xiaoping Chen</investigator_full_name>
    <investigator_title>Xiaoping Chen, professor, West China Hospital of Sichuan University.</investigator_title>
  </responsible_party>
  <keyword>hypertension</keyword>
  <keyword>renal insufficiency</keyword>
  <keyword>indapamide</keyword>
  <keyword>hydrochlorothiazide</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrochlorothiazide</mesh_term>
    <mesh_term>Indapamide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

